CONTACT
+91 80 2808 2808
ContactUs.BBL@biocon.com

Press Releases 2020

Biocon Biologics  /  News – Posts  /  Press Releases  /  Press Releases 2020

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents
  • Posted by: Biocon Biologics

Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs

  • Posted by: Biocon Biologics

Biocon Ranked Among Top 5 Biotech Employers Globally

  • Posted by: Biocon Biologics

Biocon Q2FY21 Revenue at Rs 1,760 Cr, Up 10%; EBITDA at Rs 407 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr; Generics Up 8% at Rs 599 Cr; Biosimilars Up 11% at Rs 676 Cr; Research Services Up 12% at Rs 520 Cr.

  • Posted by: Biocon Biologics

Biocon Foundation Signs MoU with Bangalore Metro to Contribute Towards Building Metro Station in Hebbagodi

  • Posted by: Biocon Biologics

Biocon Biologics to Roll Out ‘Mission 10 cents’ in Philippines; Signs MoU with 2 Municipal Governments & reach52 to enable Affordable Access to Quality Insulins

  • Posted by: Biocon Biologics

Biocon Biologics and Mylan Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes

  • Posted by: Biocon Biologics

Tata Capital Growth Fund to Invest ~USD 30 million (Rs 225 Crore) in Biocon Biologics for an Equity Stake of 0.85% Deal Values Biocon Biologics at USD 3.5 Billion.

  • Posted by: Biocon Biologics

Biocon Q1FY21 Revenue at Rs 1,690 Cr, Up 14%; EBITDA at Rs 432 Cr; Net Profit (from continuing ops) at Rs 153 Cr Generics up 16% at Rs 599 Cr, Biosimilars up 19% at Rs 692 Cr

  • Posted by: Biocon Biologics

Biocon Biologics and Voluntis Join Hands for Global Collaboration on Digital Therapeutics for Insulins

  • Posted by: Biocon Biologics
Share